Literature DB >> 6440472

Resistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.

A J Godfrey, L E Bryan.   

Abstract

An isogenic set of mutants of Pseudomonas aeruginosa, altered in permeability or permeability plus constitutive production of beta-lactamase, was examined for susceptibility to newer beta-lactam antibiotics. Kinetic data on the chromosomal beta-lactamase and susceptibility studies for the test beta-lactams indicate that permeability was the major mechanism of resistance to the poorly hydrolyzed and nonhydrolyzed antibiotics, e.g., carbenicillin, moxalactam, and cefsulodin. An exception was cefotaxime, with a low Km and a low Vmax, which had reduced efficacy in the permeability mutant and was further affected by the constitutive beta-lactamase. In this case, since the Vmax was low, a nonhydrolytic barrier may provide the additional reduction in susceptibility.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440472      PMCID: PMC179949          DOI: 10.1128/AAC.26.4.485

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

Authors:  T D Gootz; C C Sanders; R V Goering
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

2.  Antibiotics against Pseudomonas.

Authors:  A P Gillett
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

3.  Pseudomonas aeruginosa outer membrane permeability: isolation of a porin protein F-deficient mutant.

Authors:  T I Nicas; R E Hancock
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

4.  In vitro antagonism of beta-lactam antibiotics by cefoxitin.

Authors:  C C Sanders; W E Sanders; R V Goering
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

5.  Function of the outer membrane of Escherichia coli as a permeability barrier to beta-lactam antibiotics.

Authors:  W Zimmermann; A Rosselet
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

6.  Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

Authors:  D G Beckwith; J A Jahre
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

7.  Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.

Authors:  F Yoshimura; H Nikaido
Journal:  J Bacteriol       Date:  1982-11       Impact factor: 3.490

8.  Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

9.  Mutation of Pseudomonas aeruginosa specifying reduced affinity for penicillin G.

Authors:  A J Godfrey; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

10.  beta-Lactam-resistant Pseudomonas aeruginosa with modified penicillin-binding proteins emerging during cystic fibrosis treatment.

Authors:  A J Godfrey; L E Bryan; H R Rabin
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

View more
  6 in total

1.  Distribution of porin and lipopolysaccharide antigens on a Pseudomonas aeruginosa permeability mutant.

Authors:  A J Godfrey; M S Shahrabadi; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

2.  Identification of porins in outer membrane of Proteus, Morganella, and Providencia spp. and their role in outer membrane permeation of beta-lactams.

Authors:  J Mitsuyama; R Hiruma; A Yamaguchi; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

3.  Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosa.

Authors:  B L Masecar; R A Celesk; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

4.  Addition of rifampin to combination antibiotic therapy for Pseudomonas aeruginosa bacteremia: prospective trial using the Zelen protocol.

Authors:  J A Korvick; J E Peacock; R R Muder; R R Wheeler; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

5.  Mutations affecting regulation of the anabolic argF and the catabolic aru genes in Pseudomonas aeruginosa PAO.

Authors:  Y Itoh; H Matsumoto
Journal:  Mol Gen Genet       Date:  1992-02

6.  Broad-host-range gyrase A gene probe.

Authors:  N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.